Veracyte's stock dropped more than 50% following its November 4, 2026, Q3 report revealing that Decipher Prostate test volumes fell significantly below prior expectations. The company revised its annual test volume forecast down from around 20,000 to between 12,000 and 15,000 tests, and cut its 2026 revenue guidance slightly. This sharp decline has prompted Levi & Korsinsky law firm to investigate potential securities law violations related to alleged misleading statements about the test's growth outlook. Investors who suffered losses may be eligible to participate in legal action without upfront costs or court appearances.
Veracyte investigation notice is the subject, with Pluang's health sector market data as context. For readers following health stocks, here is Pluang's market snapshot as of Nov 06, 2026 07:51 WIB: out of 150 priced health-sector US stocks, 18 rose and 132 fell. Notable movers include ADMA Biologics Inc at USD 13.27 with a 1-day change of +26.62%, Inovio Pharmaceuticals Inc at USD 1.22 down 24.69%, and 10X Genomics Inc at USD 52.50 down 22.25%.
The 2026 Global Health Congress in New York gathered over 625 healthcare leaders from 25 countries to discuss innovation, equity, and investment in healthcare. The event featured 350+ startup applications in its Healthcare Shark Tank competition, cro...
Ambarella, an edge AI semiconductor company, announced its third quarter fiscal year 2027 earnings conference call will be held on November 24, 2026, at 1:30 p.m. Pacific Time. The company will release its earnings report after the market closes that...
Apple Inc. (AAPL) perpetual contracts on Hyperliquid bounced back near $350 on November 5, recovering from recent losses. A wallet added about $33.22 million to a large short position totaling roughly 150,000 contracts valued at $52.46 million, with ...
Oil prices increased as investors considered the risk of renewed military conflict between the US and Iran following the US midterm elections, alongside emerging hopes for a diplomatic solution. Brent crude rose to $99.90 per barrel and US West Texas...
Kyivstar Group Ltd reported a 17.5% year-on-year revenue increase to USD 349 million in Q3 2026, driven by higher mobile ARPU and data usage. EBITDA rose 10.3% to USD 189 million, and net profit turned positive at USD 99 million after a prior loss. D...
